Viracta Therapeutics viracta.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Viracta Therapeutics is a clinical-stage drug development company focused on advancing a proprietary viral activation therapy platform to address cancers associated with the Epstein-Barr Virus (EBV) and additional virus-associated diseases.

Viracta Therapeutics is a clinical-stage drug development company focused on advancing a proprietary viral activation therapy platform to address cancers associated with the Epstein-Barr Virus (EBV) and additional virus-associated diseases.

Company (IPO / Went public)

Phone: 858-400-8470

Fax:

2533 S. Coast Hwy 101
Suite 210
Cardiff, 92007
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Viracta Therapeutics $142.8M Nov 30, 2020
Adastra Pharmaceuticals $90.7M Nov 1, 2019
Inimex Pharmaceuticals $25.5M Jun 13, 2008
See all 13 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Viracta Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors

Competitors

Company Status Description Investors
See all 13 competitors